Evidence map›Paper›PMID 38976585›Full record

ArticleRevista de neurologia2024

[Reversible cerebral vasoconstriction syndrome. Recurrence of thunderclap headaches after treatment with corticosteroids].

A Aldaz-Burgoa, N Rodríguez-Albacete, L Franco-Rubio, L López-Trashorras, P Abizanda-Saro, C I Gómez Escalonilla-Escobar, A López Frías-López Jurado, N González-García

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista de neurologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

A Aldaz-BurgoaHospital Clínico San Carlos, 28035 Madrid, España.
N Rodríguez-AlbaceteHospital Clínico San Carlos, 28035 Madrid, España.
L Franco-RubioHospital Clínico San Carlos, 28035 Madrid, España.
L López-TrashorrasHospital Clínico San Carlos, 28035 Madrid, España.
P Abizanda-SaroHospital Clínico San Carlos, 28035 Madrid, España.
C I Gómez Escalonilla-EscobarHospital Clínico San Carlos, 28035 Madrid, España.
A López Frías-López JuradoHospital Clínico San Carlos, 28035 Madrid, España.
N González-GarcíaHospital Clínico San Carlos, 28035 Madrid, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionReversible cerebral vasoconstriction syndrome is a clinicoradiological entity with a self-limiting course that manifests with recurrent episodes of thunderclap headache, and is associated with certain triggers. Recurrence is very rare, and the pathophysiology is thought to be related to altered autoregulation of the cerebrovascular tone. We present a clinical case that raises questions about possible recurrences and triggers. CASE REPORT: A 44-year-old woman with a history of multiple sclerosis treated with interferon beta-1b who had four episodes of thunderclap headache while resting, after completing a course of corticosteroids due to a flare-up of optic neuritis. Three years earlier, the patient had presented several episodes of explosive-onset headache during a self-limited period of one month, only occurring during sexual intercourse. In the year prior to our assessment, she had suffered three thunderclap headaches with similar characteristics, but they were triggered only by intense physical exercise. She had not consulted a physician about these events. A cranial computed tomography scan was performed after the administration of contrast media and a cerebral arteriography, which were consistent with cerebral vasoconstriction syndrome, and its reversibility was confirmed three months later.

conclusionsReversible cerebral vasoconstriction syndrome shares a phenotypic expression with primary exertion headaches. It is associated with drugs with vasoactive effects, including interferons, and corticosteroids are associated with a worse prognosis, and such their administration should be avoided.

Indexed as

Headache Disorders, PrimaryRecurrenceAdrenal Cortex HormonesAdultFemaleHumansSyndromeVasoconstrictionVasospasm, IntracranialAdrenal Cortex Hormones

Identifiers

PMID38976585
PMCPMC11469096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.